Plasma mitochondrial DNA levels are inversely associated with HIV-RNA levels and directly with CD4 counts: potential role as a biomarker of HIV replication

Autor: Álvaro Mena, Manuel Crespo, Ignacio Rego-Pérez, Francisco J. Blanco, S. Relaño, Vanesa Balboa, Andrés Tabernilla, Marta Grandal, Berta Pernas, Eva Poveda, Ángeles Castro-Iglesias
Přispěvatelé: Pharmaceutical and Pharmacological Sciences
Jazyk: angličtina
Rok vydání: 2017
Předmět:
0301 basic medicine
Male
Virus replication
Cell
Human immunodeficiency virus (HIV)
HIV Infections
medicine.disease_cause
Virus Replication
DNA
Mitochondrial/blood

Cohort Studies
Plasma
0302 clinical medicine
Pharmacology (medical)
030212 general & internal medicine
Genetics
CD4 count determination procedure
Plasma samples
virus diseases
Middle Aged
Viral Load
Mitochondrial
Infectious Diseases
medicine.anatomical_structure
HIV Infections/epidemiology
Spain/epidemiology
Biomarker (medicine)
RNA
Viral

Female
Microbiology (medical)
Adult
Mitochondrial DNA
HIV-1/genetics
Viremia
Real-Time Polymerase Chain Reaction
DNA
Mitochondrial

Andrology
03 medical and health sciences
Blood HIV RNA
Virology
medicine
Humans
Biological makers
RNA
Viral/blood

Pharmacology
business.industry
HIV
DNA
medicine.disease
HIV infection
CD4 Lymphocyte Count
030104 developmental biology
Viral replication
Spain
HIV-1
business
Biomarkers/blood
Biomarkers
Linear trend
Zdroj: RUC. Repositorio da Universidade da Coruña
instname
Popis: [Abstract] Objectives. To evaluate plasma mitochondrial DNA (mtDNA) levels among HIV-infected patients and its potential role as a biomarker of residual viral replication. Methods. HIV-infected patients on follow-up at a reference hospital in north-west Spain were selected. DNA was isolated from plasma samples and mtDNA levels were assessed using a quantitative real-time PCR assay. HIV-RNA levels and CD4+ cell counts were evaluated in the same blood samples used for plasma mtDNA quantification. Epidemiological and clinical variables were included for the analysis. Results. A total of 235 HIV-infected patients were included. Mean plasma mtDNA levels were 217 ± 656 copies/μL for naive (31.9%) and 364 ± 939 copies/μL for HIV-infected patients receiving ART and with suppressed viraemia (P = 0.043). Among the latter, mean plasma mtDNA levels were 149 ± 440 copies/μL for those with low-level viraemia (LLV; HIV-RNA 20–200 copies/mL), 265 ± 723 copies/μL for those with detected-not-quantified (DNQ) viraemia (HIV-RNA
Databáze: OpenAIRE